亿帆医药：在研项目F-652的aGVHD适应症此前已在美国获得临床批件，将优先开展国内临床试验

Group 1 - The core point of the article is that Yifan Pharmaceutical (002019) has received clinical approval for its research project F-652 for aGVHD indication in the United States and will prioritize conducting domestic clinical trials [1]